Status: Recruiting
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
To determine whether using bpMRI in subjects who are at high risk of developing prostate cancer in conjunction with PSA will improve prostate cancer screening protocols.
Participants needed: 100
Trial details
Age: 40-55Biological sex: MaleType: InterventionalSponsor: Northwell HealthUpdated: Nov 24, 2025Locations: 1
Eligibility criteria
PSA between 1.0 and 2.5 ng/dL [+3]
Nodularity or firmness of prostate on exam [+6]